BridgeBio Pharma, Inc.
BBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001743881
In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 5 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by BridgeBio Pharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 5 filings
- 4 insiders, $19.2M in total
- Insiders trading
- 4
- Net value
- −$19.2M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for BridgeBio Pharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kumar Neil | Chief Executive Officer | 495,686Indirect | Sep 21, 2026 | 20 |
| Trimarchi Thomas | President and CFO | 336,529 | Aug 18, 2026 | 6 |
| Apuli Maricel | Chief Accounting Officer | 122,687 | Aug 18, 2026 | 10 |
| Ellis Andrea | Director | 22,579 | Jul 13, 2026 | 3 |
| Cook Jennifer E. | Director | 8,383 | Jul 13, 2026 | 3 |
| Hassan Fred | Director | 29,879 | Jun 24, 2026 | 1 |
| Daniels Ronald J | Director | 20,981 | Jun 24, 2026 | 2 |
| Homcy Charles J | Director | 919,876 | Jun 24, 2026 | 2 |
| Momtazee James C | Director | 19,070 | Jun 24, 2026 | 1 |
| McCormick Frank | Director | 10,579 | Jun 24, 2026 | 3 |
| Aguiar Eric | Director | 10,579 | Jun 24, 2026 | 1 |
| Satvat Ali J. | Director | 169,983 | Jun 24, 2026 | 1 |
| Dachille Douglas A. | Director | 10,579 | Jun 24, 2026 | 1 |
| Lo Andrew | Director | 18,079 | Jun 24, 2026 | 2 |
| Valantine Hannah | Director | 9,259 | Jun 24, 2026 | 4 |
| Scott Randal W. | Director | 11,589 | May 19, 2026 | 3 |
| Viking Global Investors LP | 10% Owner | 18,555,375Indirect | Jul 1, 2025 | 0 |
| Halvorsen Ole Andreas | 10% Owner | 18,555,375Indirect | Jul 1, 2025 | 0 |
| Ott David C. | 10% Owner | 18,555,375Indirect | Jul 1, 2025 | 0 |
| Viking Global Opportunities Portfolio GP LLC | 10% Owner | 18,555,375Indirect | Jul 1, 2025 | 0 |
| Viking Global Opportunities GP LLC | 10% Owner | 18,555,375Indirect | Jul 1, 2025 | 0 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% Owner | 18,555,375Indirect | Jul 1, 2025 | 0 |
| Shabet Rose Sharon | 10% Owner | 18,555,375Indirect | Jul 1, 2025 | 0 |
| Viking Global Opportunities Parent GP LLC | 10% Owner | 18,555,375Indirect | Jul 1, 2025 | 0 |
| Kravis Henry R | 10% Owner | 13,260,971Indirect | May 14, 2025 | 0 |
| Roberts George R | 10% Owner | 13,260,971Indirect | May 14, 2025 | 0 |
| KKR & Co. Inc. | 10% Owner | 13,260,971Indirect | May 14, 2025 | 0 |
| KKR Management LLP | 10% Owner | 13,260,971Indirect | May 14, 2025 | 0 |
| KKR Group Partnership L.P. | 10% Owner | 13,260,971Indirect | May 14, 2025 | 0 |
| KKR Group Holdings Corp. | 10% Owner | 13,260,971Indirect | May 14, 2025 | 0 |
| KKR Genetic Disorder L.P. | 10% Owner | 13,260,971Indirect | May 14, 2025 | 0 |
| KKR Genetic Disorder GP LLC | 10% Owner | 13,260,971Indirect | May 14, 2025 | 0 |
| KKR Group Co. Inc. | 10% Owner | 13,260,971Indirect | May 14, 2025 | 0 |
| Stephenson Brian C | CFO and Treasurer | 102,464 | Feb 27, 2025 | 0 |
| Scheller Richard H | Director | 53,822 | Feb 21, 2023 | 0 |
| Saunders Brent L | Director | 17,600 | Jun 24, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 (view filing) | Feb 17 | 1 day | Trimarchi ThomasPresident and CFO | SSale | −13.6K | $74.72 | −$1.02M | −3.9%336.6K after | 2 lots10b5-1 |
| Feb 18, 2026 (view filing) | Feb 17 | 1 day | Apuli MaricelChief Accounting Officer | SSale | −510 | $74.31 | −$37.9K | −0.4%123.9K after | 10b5-1 |
| Feb 23, 2026 (view filing) | Feb 19 | 4 days | Kumar NeilChief Executive Officer | SSale | −28.1K | $71.39 | −$2.00M | −10.7%234.5K after | 3 lots10b5-1 |
| Feb 27, 2026 (view filing) | Feb 26 | 1 day | Apuli MaricelChief Accounting Officer | SSale | −2.00K | $66.00 | −$132.0K | −1.6%121.9K after | 10b5-1 |
| Mar 3, 2026 (view filing) | Feb 27 | 4 days | Valantine HannahDirector | SSale | −25.5K | $67.41 | −$1.72M | −77.3%7.46K after | 2 lots10b5-1 |
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | Ellis AndreaDirector | SSale | −64.9K | $64.87 | −$4.21M | −77.7%18.6K after | 10b5-1 |
| Mar 12, 2026 (view filing) | Mar 10 | 2 days | Valantine HannahDirector | SSale | −8.67K | $72.00 | −$624.3K | −53.7%7.46K after | 10b5-1 |
| Mar 16, 2026 (view filing) | Mar 12-13 | 4 days | Kumar NeilChief Executive Officer | SSale | −80.0K | $68.76 | −$5.50M | −1.8%4.44M after | 10 lots10b5-1 |
| Apr 13, 2026 (view filing) | Apr 9-10 | 4 days | Kumar NeilChief Executive Officer | SSale | −80.0K | $74.61 | −$5.97M | −1.8%4.40M after | 8 lots10b5-1 |
| May 4, 2026 (view filing) | Apr 30 | 4 days | Apuli MaricelChief Accounting Officer | SSale | −2.00K | $71.58 | −$143.2K | −1.5%134.1K after | 10b5-1 |
| May 11, 2026 (view filing) | May 7-8 | 4 days | Kumar NeilChief Executive Officer | SSale | −80.0K | $67.40 | −$5.39M | −1.8%4.36M after | 12 lots10b5-1 |
| May 19, 2026 (view filing) | May 15 | 4 days | Scott Randal W.Director | SSale | −10.0K | $67.15 | −$671.5K | −46.3%11.6K after | 4 lots10b5-1 |
| May 19, 2026 (view filing) | May 18 | 1 day | Trimarchi ThomasPresident and CFO | SSale | −13.7K | $65.08 | −$888.5K | −3.7%359.2K after | 2 lots10b5-1 |
| May 26, 2026 (view filing) | May 21 | 5 days | Kumar NeilChief Executive Officer | SSale | −26.1K | $69.44 | −$1.81M | −9.7%243.3K after | 5 lots10b5-1 |
| Jun 8, 2026 (view filing) | Jun 4-5 | 4 days | Kumar NeilChief Executive Officer | SSale | −80.0K | $67.67 | −$5.41M | −1.8%4.32M after | 14 lots10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Cook Jennifer E.Director | SSale | −90.2K | $66.63 | −$6.01M | −93.2%6.59K after | 2 lots10b5-1 |
| Jun 24, 2026 (view filing) | Jun 22-23 | 2 days | Valantine HannahDirector | SSale | −5.00K | $68.25 | −$341.5K | −35.1%9.26K after | 2 lots10b5-1 |
| Jun 24, 2026 (view filing) | Jun 23-24 | 1 day | Cook Jennifer E.Director | SSale | −39.4K | $69.92 | −$2.75M | −82.4%8.38K after | 2 lots10b5-1 |
| Jul 13, 2026 (view filing)4:40 PM ET | Jul 9 | 4 days | Cook Jennifer E.Director | SSale | −148.6K | $88.54 | −$13.2M | −94.7%8.38K after | 2 lots10b5-1 |
| Jul 13, 2026 (view filing)4:41 PM ET | Jul 9 | 4 days | Ellis AndreaDirector | SSale | −17.2K | $84.00 | −$1.44M | −43.2%22.6K after | 10b5-1 |
| Aug 3, 2026 (view filing)4:20 PM ET | Jul 30 | 4 days | Apuli MaricelChief Accounting Officer | SSale | −2.00K | $80.06 | −$160.1K | −1.5%127.4K after | 10b5-1 |
| Aug 20, 2026 (view filing)4:31 PM ET | Aug 18 | 2 days | Kumar NeilChief Executive Officer | SSale | −35.0K | $82.53 | −$2.89M | −12.6%243.3K after | 4 lots10b5-1 |
| Aug 20, 2026 (view filing)4:31 PM ET | Aug 19 | 1 day | Kumar NeilChief Executive Officer | SSale | −10.0K | $84.03 | −$840.3K | −1.9%505.7K after | 3 lots10b5-1 |
| Sep 21, 2026 (view filing)6:21 PM ET | Sep 17 | 4 days | Kumar NeilChief Executive Officer | SSale | −10.0K | $69.08 | −$690.8K | −2.0%495.7K after | 2 lots10b5-1 |